Wolfgang Hoffmann, MD

Articles by Wolfgang Hoffmann, MD

UFT Plus Calcium Folinate Plus Radiotherapy for Recurrent Rectal Cancer

ByWolfgang Hoffmann, MD,Martina Schiebe, MD,Juergen Dethling, MD,Christophe Martin, MD

July 1st 1999

Uracil and tegafur (in a molar ratio of 4:1 [UFT]) plus calcium folinate comprise the components of the oral agent, Orzel, which appears to have activity comparable to intravenously administered 5-fluorouracil. This article

Latest Updated Articles

UFT Plus Calcium Folinate Plus Radiotherapy for Recurrent Rectal Cancer
Published: July 1st 1999 | Updated:

Wolfgang Hoffmann, MD

Articles by Wolfgang Hoffmann, MD

UFT Plus Calcium Folinate Plus Radiotherapy for Recurrent Rectal Cancer

Latest Updated Articles

Trending on CancerNetwork

ESMO 2025: The Top 10 Takeaways That May Shift Oncology Practice

ctDNA Status May Determine Adjuvant Immunotherapy Benefit in MIBC

Frontline Tislelizumab Combo Improves Long-Term Survival in ES-SCLC

FDA Approves Revumenib in R/R NPM1-Mutant AML

Awareness Fuels Progress: Upcoming Advances in Breast Cancer Treatment